Hematopoietic stem cell transplantation for sickle cell disease: The changing landscape
Allogeneic hematopoietic stem cell transplantation (HSCT) remains the only curative therapy for sickle cell disease (SCD); however, its use is limited by lack of suitable human leukocyte antigen (HLA)-matched donors and decreased application in older patients with significant morbidity. Myeloablativ...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wolters Kluwer Medknow Publications
2017-10-01
|
| Serie: | Hematology/Oncology and Stem Cell Therapy |
| Soggetti: | |
| Accesso online: | https://journals.lww.com/10.1016/j.hemonc.2017.05.008 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|